Open-Label Extension Study of Setmelanotide in Patients with a Rare Genetic, Syndromic or Acquired Disease of the MC4R Pathway

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2026
This article has no abstract
Epistemonikos ID: be2b2c41b6ac10e305e50d66870c2a4384000946
First added on: Oct 23, 2026